FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
The latest: Cancer screening company Burning Rock Biotech Ltd. (BNR.US) announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National…
RELATED ARTICLES
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
Kindstar Globalgene finds bargain in solid tumor testing acquisition
9960.HK
- Bayzed joins IPO quest as medical rivalry heats up
-
New Horizon Health launches probe into disputed sales figures
6606.HK
-
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
GRCL.US
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK
Discover hidden China stock gems in our weekly newsletter